Blood clotting abnormalities reveal COVID-19 patients at risk for thrombotic events


Blood clotting abnormalities reveal COVID-19 patients at risk for thrombotic events
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection Credit: American College of Surgeons

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke. Their study, which was one of the first to build on growing evidence that COVID-19-infected patients are highly predisposed to developing blood clots, linked blood clotting measurements with actual patient outcomes. The research team is now participating in a randomized clinical trial of a drug that breaks down blood clots in COVID-19-infected patients. “This is an early step on the road to discovering treatments to prevent some of the complications that come with this disease,” said Franklin Wright, MD, FACS, lead author of the research article and an assistant professor of surgery at the University of Colorado School of Medicine. Their research is published as an “article in press” on the Journal of the American College of Surgeons website ahead of print.

Patients who are critically ill regardless of cause can develop a condition known as disseminated intravascular coagulation (DIC). The of these patients initially forms many clots in small blood vessels. The body’s natural clotting factors can form too much or eventually not be able to effectively form any clot leading to issues of both excessive clotting and excessive bleeding. However, in patients with COVID-19 the clotting appears to be particularly severe and—as evidenced by in China and elsewhere—clots in COVID-19 patients do not appear to dissipate, explained Dr. Wright.

Trauma acute care surgeons and intensive care physicians who treat trauma, transplant, and cardiothoracic surgery patients at UC Health University of Colorado Hospital saw the potential of using a specialized coagulation test to examine clotting issues in COVID-19 patients. Thromboelastography (TEG) is a whole blood assay that provides a broad picture of how an individual patient’s blood forms clots, including how long clotting takes, how strong clots are, and how soon clots break down. TEG is highly specialized and used primarily by surgeons and anesthesiologists to evaluate the efficiency of blood clotting; it is not widely used in other clinical settings. “The COVID pandemic is opening doors for multidisciplinary collaboration so trauma acute care surgeons and intensivists can bring the tools they use in their day-to-day lives and apply them in the critical care setting to new problems,” Dr. Wright said.






Journal of the American College of Surgeons research findings highlight early research on blood clotting evaluation work that may help identify and treat dangerous complications of COVID-19. Commentary by lead study author Franklin Wright, MD, FACS, University of Colorado School of Medicine. Credit: American College of Surgeons

The researchers evaluated outcomes for all patients who had a TEG assay as part of their treatment for COVID-19 infection as well as other conventional coagulation assays, including ones that measure D-dimer levels. D-dimer is a protein fragment that is produced when a blood clot dissolves. D-dimer levels are elevated when large numbers of clots are breaking down.

A total of 44 patients treated for COVID-19 infection between March 22 and April 20 were included in the analysis. Those whose bodies were not breaking down clots most often required hemodialysis and had a higher rate of clots in the veins. These patients were identified by TEG assays showing no clot breakdown after 30 minutes and a D-dimer level greater than 2600 ng/mL. Eighty percent of patients with both affirmative test findings were placed on dialysis compared with 14 percent who tested for neither finding. Patients with affirmative test findings also had a 50 percent rate of venous compared with 0 percent for those patients with neither finding.

“These study results suggest there may be a benefit to early TEG testing in institutions that have the technology to identify COVID-19 patients who may need more aggressive anticoagulation therapy to prevent complications from clot formation,” Dr. Wright said.






Early and aggressive blood-thinning medication may have a role in preventing complications in certain COVID-19 patients, according to research findings appearing in the Journal of the American College of Surgeons. Commentary by lead study author Franklin Wright, MD, FACS, University of Colorado School of Medicine. Credit: American College of Surgeons

A clinical trial of one form of treatment is already underway. The Denver Health and Hospital Authority is leading a multi-center study that includes UC Health University of Colorado Hospital, National Jewish Health-St Joseph Hospital, Beth Israel Deaconess Medical Center, and Long Island Jewish Hospital in conjunction with Genentech, Inc., enrolling patients with COVID-19 infection in a randomized clinical trial of tissue plasminogen activator (tPA). This drug is a natural anticoagulant that was approved by the U.S. Food and Drug Administration in 1996 for the treatment of diseases associated with clotting disorders, such as heart attack, stroke, and pulmonary embolism. The trial will assess the efficacy and safety of intravenous tPA in improving respiratory function and management of patients with aggressive blood clotting.

“This study suggests that testing whole blood clotting measurements may allow physicians to identify and treat patients with COVID-19 more effectively to prevent complications and encourage further research into therapies to prevent blood clots in these patients,” Dr. Wright said.


Blood clotting a significant cause of death in patients with COVID-19


More information:
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection. Journal of the American College of Surgeons. DOI: 10.1016/j.jamcollsurg.2020.05.007

Citation:
Blood clotting abnormalities reveal COVID-19 patients at risk for thrombotic events (2020, May 15)
retrieved 16 May 2020
from https://medicalxpress.com/news/2020-05-blood-clotting-abnormalities-reveal-covid-.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



loading...

Related posts:

New study confirms important clues to fight ovarian cancer
Coronavirus infections may lead to delirium and potentially PTSD
Evolutionäre Zielkonflikte können die Entwicklung von Antibiotikaresistenzen nicht verhindern
Small risk of muscle and bone problems in babies of mothers who took common thrush treatment
Italy to reopen borders on June 3 to restart tourism
Keeping kids slim, fit during lockdown isn't easy: Here are some tips
The cholera outbreak in a Victorian asylum that anticipated the coronavirus crisis in care homes
COVID-19 disruption will lead to 28 million surgeries cancelled worldwide
Schwangerschaft: "Natürlich" bedeutet nicht automatisch gesund
Klaus Tschira Stiftung unterstützt Sepsis-Forschung
Forscher bestätigen Zusammenhang zwischen CED und Zöliakie
Besonders fitte Antikörper sollen gegen SARS-CoV-2 helfen
Slovenia opens borders after declaring epidemic over
Verlässlicher Schutz für Patienten und Mitarbeiter: Aufnahmescreening auf SARS-CoV-2
Using telehealth to transition diabetes inpatients to virtual care during COVID-19
Zu wenig Schlaf hängt auch bei Erwachsenen mit häufigeren Asthmaanfällen zusammen
Virus could cut up to 9.7 percent off global economy: ADB
Live poultry linked to Salmonella cases in 28 states
5 ways to help stop the 'infodemic,' the increasing misinformation about coronavirus
Immunantwort nach Corona-Infektion im Blick
US regulators approve new type of contraceptive gel
UK PM Johnson backs key aide over lockdown breach claims
Warum Lymphdrüsenkrebs das Gehirn befällt
CDC, states' reporting of virus test data causes confusion
Kinder und Jugendliche psychisch stark machen – Neues Infoportal geht ans Netz
EU calls for independent probe of WHO's pandemic response
Woche des Sehens 2020: "Die Zukunft im Auge behalten"
High-quality end-of-life care will enable older people with frailty to live well and die well
Germans opt for staycations as virus fears linger
Sleep-wake disturbances can predict recurrent events in stroke survivors
Researchers find potential drug treatment targets for alcohol-related liver disease
Endgültiges Aus für Mentholzigarette in der EU
A child's brain activity reveals their memory ability
Analysemethoden nehmen Einfluss auf das Ergebnis
Are we wired for romance? fMRI imaging and genetic analysis say yes
Gentherapie: Neues Verfahren zur kontinuierlichen Produktion viraler Vektoren
Russia says virus cases under 9,000 for first time since May 1
Hemmung zelleigenen Enzyms: Strategie für Entwicklung antiviraler Breitbandwirkstoffe
Clinical trial shows ability of stem cell-based topical solution to regrow hair
Researchers link gene mutation to autism behaviors
App will reduce high risk of falls during and after lockdown
Xtreme Research Award: Prof. Nolan für Arbeiten zum Makulapigment ausgezeichnet
Germany kicks off as Europe eases curbs but virus marches on
Mental ill health 'substantial health concern' among police, finds international study
India extends nationwide lockdown until end of May
Aldosterone production is a common and unrecognized cause of high blood pressure
Bakterien nutzen NO, um Schleimhaut zu besiedeln
How mindfulness can help amid the COVID-19 pandemic
Regular aspirin use tied to lower risk for digestive tract cancers
US poised to ban travel from Brazil: White House aide
Study finds association between atherosclerosis and changes in the structure, heart function
Neue Angiographie-Einheit erweitert Behandlungsmöglichkeiten deutlich
Antivirales Medikament gegen COVID-19 erstmalig am Dresdner Uniklinikum erfolgreich eingesetzt
Common misunderstandings doctors confront about preventing pregnancy
Faktencheck: Augenherpes wegen Mundschutz? Zusammenhang nicht belegt
Zi-Studie zur Inanspruchnahme der Darmkrebsfrüherkennung veröffentlicht
Noch keine ausreichende Evidenz zur Plasmatherapie gegen COVID-19
UK's COVID-19 study aims to vaccinate more than 10,000
Coronavirus cases top five million worldwide
Certain environmental chemicals linked with poor kidney health
California hospitals saw sharp drop in heart attacks during COVID-19 shutdown
WHO: Corona-Ansteckung durch Berührung von Oberflächen nicht bewiesen
UK govt boosts vaccine funding as daily virus deaths fall
Ärzte-Statistik: 402.000 Ärzte in Deutschland
What can a COVID-19 antibody test tell me?
Nearly quarter of a billion people in Africa will catch coronavirus and up to 190,000 could die
IQWiG bleibt dabei: Nutzen des PSA-Screenings wiegt den Schaden nicht auf
Madagascar's 'green gold' against COVID-19 seeks nod beyond Africa
New research finds 'Dr. Google' is almost always wrong
Canada and the U.S. working on extending border closure
Study finds childhood cancer does not affect parental separation, divorce, and family planning in De...
New study could pave way to cure of global parasite
Leibniz-WissenschaftsCampus EvoLUNG erhält erneut Förderung
Americans and Europeans soak up the sun amid new rules
Coronavirus deaths top 325,000 worldwide
PM Johnson says Britain could reopen stores on June 15
WHO suspends hydroxychloroquine trial as COVID-19 treatment
COVID-19 death counts 'substantial underestimation' of actual deaths for some Italian regions
Study reveals mental health of medical personnel working with COVID-19 patients
Minimum legal age for cannabis use should be 19, study suggests
Krebs im Kindesalter: Den richtigen Zeitpunkt für ein Gespräch zum Lebensende finden
Cord blood study provides insights on benefits, limitations for autism treatment
Preclinical study offers hope for Hirschsprung's disease
Turkey records 29 deaths, 987 new COVID-19 cases
Children unlikely to be the main drivers of the COVID-19 pandemic
Abnormalities detected on brain MRI of COVID-19 patients in ICU
No new virus deaths in Ireland for first time 10 weeks
Weniger indolente, mehr aggressive Prostatakarzinome
US bans Brazil travel over virus surge as Europe keeps easing
Loosened restrictions, holiday weekend to test California
Local health agencies struggle to ramp up virus tracking
Sociodemographic factors associated with a positive test for COVID-19 in primary care
Experts share what you need to know about COVID-19 as states reopen
Urlaub zuhause: Auch im Kräutergarten an Zecken denken
Interdisziplinäre zentrale Ultraschalleinheit des UKL als Ausbildungsstätte anerkannt
Online exercise advice rarely aligns with national physical activity guidelines
Countering the negative effects of a common antidepressant
Corona-Antikörpertests: Sichere Ergebnisse im Fokus
Genetische Ursachen für die nicht-alkoholische Fettleber
Leitlinie „Neurogene Dysphagie“ komplett überarbeitet

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Intervenimi i patrullës policore të autostradës, parandalon vet-hedhjen nga ura e një të riu

Sat May 16 , 2020
Komunikatë për media Intervenimi i patrullës policore të autostradës, parandalon vet-hedhjen nga ura e një të riu Prishtinë, 16 maj 2020 Sot, më, 16.05.2020, rreth orës 12:50, një njësi patrulluese e autostradës, derisa ishte në patrullim rutinë në pjesën e autostradës Trudë-Mazgit, pikërisht në urën e autostradës në fshatin Bardhosh, […]
Intervenimi i patrullës policore të autostradës, parandalon vet-hedhjen nga ura e një të riu